A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma

A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma

Background: Cellular senescence has recently been considered a new cancer hallmark. However, the factors regulating cellular senescence have not been well characterized. The aim of this study is to identify long non-coding RNAs (lncRNAs) associated with senescence and prognosis in patients with lung...

Full description

Bibliographic Details
Main Authors:	Xueying Fang, Enmin Huang, Xiaopeng Xie, Kai Yang, Shuqian Wang, Xiaoqing Huang, Mei Song
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Genetics
Subjects:	cellular senescence lncRNA prognosis tumor microenvironment immunotherapy lung adenocarcinoma
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.951311/full

Similar Items

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis
by: Chengyu Bian, et al.
Published: (2022-08-01)

Reciprocal Regulation between lncRNA ANRIL and p15 in Steroid-Induced Glaucoma
by: Peixing Wan, et al.
Published: (2022-04-01)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
by: Pengpeng Zhang, et al.
Published: (2023-01-01)

A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma
by: Zipei Song, et al.
Published: (2024-02-01)

An anoikis-related lncRNA signature is a useful tool for predicting the prognosis of patients with lung adenocarcinoma
by: Xin Jiang, et al.
Published: (2023-11-01)

Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma
by: Kefan Lin, et al.
Published: (2023-04-01)

Metabolism‐related lncRNAs signature to predict the prognosis of colon adenocarcinoma
by: Yimin Sun, et al.
Published: (2023-03-01)

An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
by: Xueyuan Huang, et al.
Published: (2023-01-01)

Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment
by: Yuanyong Wang, et al.
Published: (2022-08-01)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
by: Tianyou Liao, et al.
Published: (2022-10-01)

Identification and Application of a Novel Immune-Related lncRNA Signature on the Prognosis and Immunotherapy for Lung Adenocarcinoma
by: Zhimin Zeng, et al.
Published: (2022-11-01)

In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma
by: Yue Wang, et al.
Published: (2022-09-01)

Integrated Dissection of lncRNA-miRNA-mRNA Pairs and Potential Regulatory Role of lncRNA PCAT19 in Lung Adenocarcinoma
by: Xiaomei Tang, et al.
Published: (2022-01-01)

Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
by: Jie Zhao, et al.
Published: (2022-11-01)

Construction of stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance
by: Lina Lu, et al.
Published: (2023-12-01)

A Novel m6A-Related LncRNA Signature for Predicting Prognosis, Chemotherapy and Immunotherapy Response in Patients with Lung Adenocarcinoma
by: Yefeng Shen, et al.
Published: (2022-08-01)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
by: Miaorong Xu, et al.
Published: (2022-07-01)

A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma
by: Hai-Bo Zhang, et al.
Published: (2023-09-01)

A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma
by: Zhaoxiang Song, et al.
Published: (2023-12-01)

Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs
by: Hengjia Tu, et al.
Published: (2022-11-01)

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
by: Chao Ma, et al.
Published: (2023-02-01)

Identification of m7G-Related LncRNA Signature for Predicting Prognosis and Evaluating Tumor Immune Infiltration in Pancreatic Adenocarcinoma
by: Jiawei Lu, et al.
Published: (2023-05-01)

LncRNA profile study reveals a seven-lncRNA signature predicts the prognosis of patients with colorectal cancer
by: Rui Huang, et al.
Published: (2020-02-01)

Genome instability-related LINC02577, LINC01133 and AC107464.2 are lncRNA prognostic markers correlated with immune microenvironment in pancreatic adenocarcinoma
by: Yinjiang Zhang, et al.
Published: (2023-05-01)

Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma
by: Weijie Xue, et al.
Published: (2023-09-01)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
by: Chong Li, et al.
Published: (2023-06-01)

An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer
by: Shun Gao, et al.
Published: (2023-03-01)

Involvement of lncRNA TUG1 in HIV-1 Tat-Induced Astrocyte Senescence
by: Prakash P. Pillai, et al.
Published: (2023-02-01)

A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
by: Mengzhe Zhang, et al.
Published: (2023-09-01)

Exploration of Identification and Prognostic Analysis of a Novel Immune-Related lncRNA Pair Signature and Immune Landscape in Esophageal Adenocarcinoma: A New Method Based on “Continuous Learning” Model
by: Yang Yu, et al.
Published: (2023-06-01)

Editorial: lncRNA in plants: function, mechanisms and applications
by: Jun Cui
Published: (2023-06-01)

Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs
by: Saiyidan Yalimaimaiti, et al.
Published: (2023-03-01)

Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma
by: Jun-Song Zhang, et al.
Published: (2023-03-01)

Integrated Dissection of lncRNA-Perturbated Triplets Reveals Novel Prognostic Signatures Across Cancer Types
by: Yunzhen Wei, et al.
Published: (2020-08-01)

The role of pyroptosis-related lncRNA risk signature in ovarian cancer prognosis and immune system
by: Yanling Wu, et al.
Published: (2023-08-01)

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
by: Yuchen Bai, et al.
Published: (2022-11-01)

Construction of lncRNA-m6A gene-mRNA regulatory network to identify m6A-related lncRNAs associated with the progression of lung adenocarcinoma
by: Jiangzhou Zhang, et al.
Published: (2023-08-01)

miRNA and lncRNA Expression Networks Modulate Cell Cycle and DNA Repair Inhibition in Senescent Prostate Cells
by: Willian A. da Silveira, et al.
Published: (2022-01-01)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
by: Jingyi Wu, et al.
Published: (2023-09-01)

LncRNA PVT1 Is a Poor Prognosticator and Can Be Targeted by PVT1 Antisense Oligos in Gastric Adenocarcinoma
by: Yuan Li, et al.
Published: (2020-10-01)